Amyris has a market cap of $188 million and an enterprise value of $250.89 million. This stock trades at a reasonable valuation, with a price-to-sales of 1.70 and a price-to-book of 2.39. Its estimated growth rate for this year is 32.7%, and for next year it's pegged at 43%. This is not a cash-rich company, since the total cash position on its balance sheet is $44.43 million and its total debt is $109.90 million. A director just bought 3.4 million shares, or about $9.99 million worth of stock, at $2.98 per share. Another director also just bought 1.7 million shares, or about $4.99 million worth of stock, at $2.98 per share. From a technical perspective, AMRS is currently trending above both its 50-day and 200-day moving averages, which is bullish. This stock has been uptrending for the last month and change, with shares moving higher from a low of $2.16 a share to its recent high of $3.56 a share. During that move, shares of AMRS have been mostly making higher lows and higher highs, which is bullish technical price action. That move has now pushed AMRS within range of triggering a near-term breakout trade. If you're in the bull camp on AMRS, then I would look for long-biased if this stock manages to break out above some near-term overhead resistance levels at $3.41 to $3.56 a share with high volume. Look for a sustained move or close above those levels with volume that registers near or above its three-month average action of 307,377 shares. If that breakout hits soon, then AMRS will set up to re-test or possibly take out its next major overhead resistance levels at $4.23 to $4.51 a share. Any move above those levels and more resistance at $4.56 a share will then put $6 into focus for shares of AMRS. Weatherford International One name in the oil well services complex that insiders are warming up to here is Weatherford International ( WFT). This company is a global provider of products and services that span the drilling, evaluation, completion, production and intervention cycles of oil and natural gas wells. Insiders are buying this stock into modest weakness, since shares are down by 10.8% in the last six months.